Archive: A New Insight into Parkinson’s Disease Protein
New research by UCSF neuroscientist Robert Edwards has uncovered the role alpha-synuclein plays in the normal brain. The protein has long been implicated in Parkinson’s disease.
University of California San Francisco
Give to UCSFNew research by UCSF neuroscientist Robert Edwards has uncovered the role alpha-synuclein plays in the normal brain. The protein has long been implicated in Parkinson’s disease.
Interim Dean Sandra Weiss of the UCSF School of Nursing is leading three major studies aimed at shedding important light on some of the most pressing issues facing American women with depression and the clinicians who treat them.
Ying-Hui Fu, a UCSF professor of neurology and a pioneer in the study of sleep and genetics, explains the science behind strange sleep patterns and shares why shut-eye is more important than you think.
A genome sequencing test developed at UCSF that can rapidly pinpoint the cause of a bacterial, viral, fungal or parasitic infection is now available to help physicians nationwide diagnose cases.
UCSF scientists used an experimental drug to completely reverse severe learning and memory impairments caused by traumatic brain injury in mice.
Around one in five children with Tourette syndrome, a neurological disorder characterized by involuntary movements and vocalizations, met criteria for autism in a study headed by UCSF.
Researchers at UCSF have found that older people with persistent pain show quicker declines in memory as they age and are more likely to have dementia years later.
UCSF researchers have drawn a link between genetic abnormalities in neurodegenerative diseases and the formation of RNA foci, work the scientists said may open avenues to the development of new drug treatments.
Researchers made a significant advance, identifying the first “high-confidence” risk gene for Tourette disorder as well as three other probable risk genes.
After undergoing surgery, elderly patients often experience cloudy thinking. Mounting evidence suggests that heightened inflammation in the brain following surgery is the more likely cause.
A newly approved drug that is the first to reflect the current scientific understanding of multiple sclerosis is holding new hope for the hundreds of thousands Americans living with the disease. It also highlights the importance of clinician scientists like UCSF’s Stephen Hauser who are working to transform research into cures for patients.
Neuroimaging is helping to distinguish between depression and dementia – two diseases with overlapping symptoms that can be difficult to diagnose properly.
Studying brain disorders is complicated for many reasons, not the least being the ethics of obtaining living neurons. To overcome that obstacle, UCSF postdoc Aditi Deshpande is starting with skin cells.
In an unprecedented leap from lab to patients, a potential treatment for childhood epilepsy identified in experiments with zebrafish.
New research is paving the way to a precision medicine approach to the diagnosis and treatment of patients with traumatic brain injury.
Poor performance on a simple odor identification test was associated with a significantly increased risk of developing dementia years later.
Distinct sets of genetic defects in a single neuronal protein can lead either to infantile epilepsy or to autism spectrum disorders.
A common treatment for irregular heartbeats known as catheter ablation may result in the formation of brain lesions when it is performed on the left side of the heart.
UC San Francisco and Pfizer Inc.’s Centers for Therapeutic Innovation have renewed an agreement to identify and develop biologic compounds against both known and novel targets.
In findings that show the effectiveness of a new strategy for treating multiple sclerosis, researchers are reporting positive results from three large, international, multicenter Phase III clinical trials of the investigational drug ocrelizumab in both relapsing multiple sclerosis and primary progressive multiple sclerosis.
UCSF scientists have discovered an unexpected mechanism the brain uses to seamlessly compensate when speech sounds are obscured by noise.
Stories about sensory processing disorder, videos about “zombie” cancer cells, and news about the effects of caffeine and alcohol on the heart were among the topics that most engaged our readers in 2016.
A shared biological mechanism may drive the progression of both Alzheimer’s disease and chronic traumatic encephalopathy, a neurodegenerative condition associated with repeated concussions and brain trauma.
UCSF researchers identified fetal brain tissue cells that are targeted by the Zika virus and determined that azithromycin can prevent the virus from infecting these cells.
UCSF researchers have received $1.2 million for their work to make imaging machines smarter, so they can detect neurological emergencies and triage patients for immediate treatment.
Next-generation sequencing for patients at UCSF Medical Center is prompting changes in brain tumor diagnoses for some children and a retooling of treatment plans in many cases.
Research led by UCSF scientists has revealed that mutations in a gene linked with brain development may dispose people to multiple forms of psychiatric disease by changing the way brain cells communicate.
Researchers at UCSF have discovered a previously unknown mass migration of inhibitory neurons into the brain’s frontal cortex during the first few months after birth.
Using a mouse model of multiple sclerosis, UCSF scientists demonstrated that regenerating myelin can both protect neurons from damage and restore lost function.